Sales & Marketing FH25: Individual centric investing with Steve Seuntjens In a new FH25 podcast episode, Deep Dive editor Eloise McLennan speaks with Steve Seuntjens, Partner at PHS Capital.
Sales & Marketing Pharma and health advertising: Brian Coane on the necessity ... Brian Coane, health partner at Leith, talks sensitivity, maximum impact, and overcoming the fear of getting humour in pharma advertising wrong.
R&D The glimmer of opportunity behind the storm: Ali Pashazadeh ... Former surgeon and investment banker Ali Pashazadeh, CEO of Treehill, discusses the current ‘perfect storm’ in biotech.
Digital FH25: The intersection of tech, science & design with Unity ... In this episode of the FH limited podcast series, web editor Nicole Raleigh speaks with Unity Stoakes, president and co-founder of Startup Health.
R&D Changing the drug development treatment paradigm: Hilary Eat... Hilary Eaton, a rare disease advocate and chief business officer at Profluent, discusses AI-first protein design and accelerating biomedicine.
R&D Increasing trial efficiency: Adityo Prakash talks small data... Adityo Prakash, founder and CEO of Verseon, discusses small datasets, real-world scenarios, and organoids.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.